Earnings calendar

Neurocrine Biosciences, Inc. (NBIX) earnings: date, estimates, results and stock reactions

Next earnings: Q4 FY2026 on 2027-02-10 (expected, after the close). EPS estimate 2.07, revenue estimate 1.09B.

Over the last 12 reports the stock moved 8.3% on average (either way), rising 6 times and falling 6. EPS beat estimates 7 of 12 times; revenue 8 of 12. Close before the report date to the first close after it (two trading sessions, covering before-the-open and after-the-close reports).

QuarterReportedEPSEPS estimateEPS surpriseRevenueRevenue estimateStock move
Q3 FY20262026-11-023.291.91+72.3%1.12B1.04B+12.8%
Q2 FY20262026-07-302.851.85+54.1%959.0M890.3M-7.7%
Q1 FY20262026-05-051.911.22+56.6%814.5M768.3M+9.7%
Q4 FY20252026-02-111.881.80+4.4%805.5M790.5M-10.6%
Q3 FY20252025-10-282.041.58+29.1%794.9M806.8M-7.3%
Q2 FY20252025-07-301.060.98+8.2%687.5M746.4M-4.4%
Q1 FY20252025-05-050.080.54-85.0%572.6M559.6M+8.4%
Q4 FY20242025-02-061.001.62-38.3%627.7M629.4M-18.9%

NBIX stock report · Earnings calendar